Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
80.24B | 72.22B | 79.43B | 80.52B | 70.57B | Gross Profit |
16.09B | 11.68B | 11.57B | 17.97B | 16.69B | EBIT |
1.06B | -2.62B | -2.91B | 3.30B | 3.26B | EBITDA |
9.00B | 4.76B | 51.00M | 6.50B | 6.42B | Net Income Common Stockholders |
2.64B | -1.04B | -4.94B | 1.50B | 2.17B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.43B | 11.58B | 11.14B | 10.37B | 8.46B | Total Assets |
122.30B | 125.42B | 119.03B | 117.74B | 105.76B | Total Debt |
39.38B | 42.68B | 35.27B | 26.76B | 21.99B | Net Debt |
29.95B | 31.11B | 24.13B | 16.38B | 13.53B | Total Liabilities |
65.06B | 68.50B | 62.53B | 55.16B | 47.17B | Stockholders Equity |
58.47B | 56.13B | 54.08B | 59.18B | 57.23B |
Cash Flow | Free Cash Flow | |||
712.00M | -5.70B | -6.69B | -2.43B | -2.34B | Operating Cash Flow |
5.12B | 1.16B | -575.00M | 3.99B | 3.69B | Investing Cash Flow |
-3.24B | -7.14B | -6.05B | -7.40B | -7.30B | Financing Cash Flow |
-4.70B | 5.48B | 6.67B | 4.93B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥28.18B | 10.88 | 3.04% | 0.92% | -0.79% | ||
73 Outperform | ¥23.63B | 7.24 | 3.11% | 9.75% | 28.00% | ||
71 Outperform | ¥20.89B | 7.90 | 4.75% | 11.10% | ― | ||
71 Outperform | ¥18.69B | 9.74 | 3.55% | 0.78% | -5.93% | ||
69 Neutral | ¥17.52B | 6.85 | 4.62% | 0.79% | 61.23% | ||
59 Neutral | ¥19.78B | 24.99 | 5.34% | 9.40% | ― | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |
Arakawa Chemical Industries, Ltd. has announced a management change with the retirement of Director Takashi Une, effective June 25, 2025, following the expiration of his term. This change is part of the company’s ongoing efforts to adapt its leadership structure, potentially impacting its strategic direction and stakeholder relations.
Arakawa Chemical Industries, Ltd. announced an increase in its year-end dividend for the fiscal year ended March 31, 2025, raising it by 1 yen per share to 25 yen. This decision aligns with the company’s policy of actively returning value to shareholders and reflects its strong consolidated performance for FY2025.
Arakawa Chemical Industries, Ltd. has reported extraordinary gains of 1,268 million yen from the sale of investment securities for the fiscal year ending March 31, 2025. These gains have been incorporated into the company’s consolidated financial results, potentially impacting its financial standing and market perception.
Arakawa Chemical Industries, Ltd. reported a significant turnaround in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 11.1% to 80,236 million yen and a return to profitability with a profit attributable to owners of the parent at 2,644 million yen. The company also improved its equity ratio to 47.8% and maintained a steady dividend payout, indicating a stable financial position and positive outlook for stakeholders.